國恩股份(002768.SZ):目前已完成環氧丙烷羰基化反應催化劑和PHB材料的公斤級製備,並建成小批量生產線
格隆匯5月12日丨國恩股份(002768.SZ)在互動平臺表示,公司現已啓動10萬噸/年可降解聚3-羥基丁酸酯(PHB)項目,並遵循“實驗室研發-工藝包開發-中試驗證-工業化放大”的技術路線穩步推進,已從實驗室研究階段轉入模式開發階段,目前已完成環氧丙烷羰基化反應催化劑和PHB材料的公斤級製備,並建成小批量生產線,當前正同步推進催化劑迭代優化和PHB的牌號矩陣構建。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.